The initial experience of our group with the beneficial effect of chloramphenicol in the treatment of ten Malayan patients with typhoid fever was published as a preliminary report (1) . The work has been continued in the United States and we now wish to add to the earlier note detailed observations on 24 patients acutely ill with typhoid fever and five typhoid carriers who have received this antibiotic. In addition, the therapeutic results obtained in small groups of typhoid patients who were given aureomycin or polymyxin are included in this report.
METHODS

Selection and observation of patients
In all of the 33 treated acutely ill patients mentioned in the present study, the clinical diagnosis of typhoid fever was confirmed by the cultivation of Salmonella typhosa from their blood obtained prior to the initiation of specific therapy. Patients selected for treatment were in an active phase of the disease. In most instances therapy was begun within two weeks of onset of illness but two patients were first given chloramphenicol during a relapse of typhoid fever in the fifth and seventh weeks of illness. The course of the disease in the treated patients was followed by careful clinical observations and by laboratory examinations which included repeated cultures of samples of blood, feces and urine, as well as Widal tests, blood counts and other. procedures when indicated. In this study the patient's temperature was considered normal when the recording was below 99.0°F. orally, or below 100.00F. rectally.
No attempt was made to treat alternate cases with chloramphenicol. During the period of the study, however, nine patients with typhoid fever were observed who received only supportive therapy. The diagnosis in each of these untreated patients was proved by the cultivation of S. typhosa from the blood or feces.
Antibiotic therapy
Chloramphenicol. In the later period of the work a simplified regime was followed. Patients 20 through 23 received the usual large initial dose of drug after which they were given a total of 4.0 gm. daily in divided doses at eight-hour intervals during the febrile period; the dosage, still given at eight-hour intervals, was later reduced by a series of steps to 1.5 gm. daily. Vomiting was encountered rarely following the initial loading dose of drug; it occurred only when the bitter uncoated tablets were used and in no instance did it necessitate discontinuance of therapy. In the majority of patients blood levels of chloramphenicol were determined at least once daily throughout the period of treatment. For this purpose serum was obtained from a specimen of blood taken immediately before the next dose of drug was due. Ley's modification 2 Intestinal hemorrhage and perforation. Two of the usual complications of typhoid fever, namely, intestinal hemorrhage and intestinal perforation, developed in three patients in the treated series. Severe intestinal hemorrhage occurred in patient 2 and.moderate bleeding in patient 15; both made satisfactory recoveries following supportive treatment which included blood transfusions. The first patient began to bleed on the 16th day of the disease, or the seventh day of therapy, at which time his temperature was normal. The second showed signs of bleeding while still febrile on the ninth day of the disease or the second day of treatment. A brief abstract of the findings in patient 3, who developed intestinal perforation, is given below, and a graphic chart of his clinical record is reproduced as Figure 3 .
-
Patient 3. This severely ill 32-year-old Chinese male entered the hospital on the 12th day of an illness characterized by continuous fever, headache, abdominal pain and distention, occasional vomiting, and an irritating, nonproductive cough. On the 17th day of illness, when treatment was begun, additional findings consisted of muttering delirium, pulmonary rales, markedly increased abdominal distention and numerous rose spots. The blood pressure was 110/70; the pulse, 124; the white blood cell count, 4,600; the red blood cell count, 1,140,000; and the urine contained moderate amounts of albumin. Blood samples taken on the 15th day of illness and on the 17th day, immediately prior to the initial dose of drug, yielded S. typhosa upon culture.
The patient's response to chloramphenicol treatment was satisfactory as shown by the reduced toxemia, the gradual clearing of the mental state, the return of appetite and the lessening of abdominal tenderness and distention. On the third day of therapy the temperature reached normal levels and remained there for the next 36 hours. The lungs were then clear, the rose spots had disappeared and the pulse and heart sounds were of better ri/GG 20. Early convalescence was complicated by intestinal perforation on the 21st day of disease. The patient received a total of 28 gm. of chloramphenicol over a period of nine days.
quality. The patient, now rational, complained of constipation and slight abdominal distention. At this point, on the 21st day of illness, an unwise medical attendant gave, without orders, 1.0 cc. of pituitrin in an effort to relieve the gaseous distention. Apparently the increased peristalsis accompanied by a local rise of intra-intestinal pressure, which followed the pituitrin injection, resulted in a perforation presumably at the site of a typhoid ulcer. When observed several hours after this episode, the patient was in a state of collapse. Intravenous fluids and blood transfusions were given as supportive measures, and in addition, chloramphenicol therapy was supplemented by the administration of large doses of penicillin and streptomycin. During the next 12 hours the condition of the patient remained critical. There was evidence of pneumoperitoneum and severe generalized peritonitis, and the white blood cell count rose to 13,900. Some improvement was observed after 18 hours, and at the end of 36 hours it appeared that the patient would survive. By the third day after perforation active peristalsis was audible and the patient passed soft fecal material in the usual manner. From this point onward the improvement was steady; the temperature dropped to normal levels by the sixth day after perforation. About the time that the patient became afebrile the abdomen was sufficiently soft to allow palpation of a mass in the right lower quadrant; this was discernible for a week before it finally disappeared.
S. typhosa was cultured from the stool sample obtained on the 18th day of illness, i.e., 24 hours after therapy was begun. Typhoid organisms were not grown from subsequent specimens of stool or blood. The patient was discharged from the hospital on the 46th day after onset of disease.
At the time of intestinal perforation surgical intervention was intensively considered but the opinion prevailed that the patient was in too poor a condition to survive any surgical procedure. Therefore, it was decided to attempt to control the infection with the aid of combined antibiotic therapy until the perforation could be sealed off by natural processes. The results were so satisfactory that the idea of surgical intervention was no longer considered after the patient became a suitable operative risk.
Relapses of typhoid fever. Four of the 22 patients treated during their initial illnesses developed relapses. These persons (patients 6, 8, 11, and 16) had been started on chloramphenicol therapy between the eighth and 13th days of their disease and had responded in the usual manner. The relapses occurred between the 23rd and 32nd days after the onset of typhoid fever, which represented periods of ten to 16 days after drug had been discontinued or 11 to 18 days after the patients had become afebrile.
The recrudescent disease in each of these individuals was characterized by fever, mild toxemia, and the presence of S. typhosa in the blood and feces. One of the patients, No. 11, was not given specific therapy during her relapse because of an inadequate supply of the antibiotic. She ran a moderately severe course with fever for ten days. The remaining members of the group were treated between the first and fourth days of their relapse. The duration of the recurrent fever after treatment was begun varied between one and one-half and three days. S. typhosa disappeared promptly from the blood and stools of the three treated patients and did not reappear. An abstract of the case history of one of the patients whose disease relapsed and a graphic summary of the data represented in Figure 4 are presented below. there were bilateral pulmonary rales; both the liver and spleen were palpable. Two blood cultures on the 11th and 12th days of illness contained S. typhosa. The white blood cell count on admission was 2,700 and the red blood cell count was 3,720,000. On the 12th day of illness an initial oral dose of 2.2 gm. of chloramphenicol was administered. The drug was continued with 0.2 gi. doses every two hours for the succeeding eight days, which was five days after the temperature became normal. A total of 16.5 gm. of drug were given. Improvement in the clinical condition was noted after two days of antibiotic treatment and the temperature reached normal levels in less than three days. Specimens of blood taken during the second, third, and fourth days of treatment were sterile, and frequent samples of stool and urine obtained during the third week of illness were free of bacilli.
On the 31st day of illness, 16 days after the patient became afebrile and 12 days after the last dose of chloramphenicol, the patient complained of headache and that afternoon the temperature reached 102.20 F. The blood was again found to contain S. typhosa. On the second day of this clinical relapse chloramphenicol treatment was reinstituted; an initial dose of 3.0 gm. was followed by doses of 0.25 gm. every two hours for seven days. Abatement of the headache was rapid and the temperature reached normal in one and one-half days after the second course of therapy was started. The convalescence thereafter was uneventful and later blood and stool cultures did not yield typhoid organisms.
The prompt clinical response of these individuals indicated that the infecting organism responsible for the relapse was not appreciably resistant to chloramphenicol. This was further established by in vitro laboratory tests which showed that the sensitivity of the organism isolated from three of the patients during their relapses was essentially the same as the sensitivity of the organisms isolated prior to treatment.
It is to be noted that in each of the four patients with relapses the initial course of chloramphenicol had been given for a period of eight days or less. Indeed, the patients had been afebrile for from one to five days, average three, when drug was stopped. The relatively high incidence of relapses, two in ten, in the early portion of the present studies led us to the opinion that chloramphenicol therapy should be continued for a longer period of time after the patients became afebrile. Subsequent 
FIG. 4. CLINICAL RESPONSE OF TYPHOID PATIENT 6 To CHLORAMPHENICOL THERAPY
A total of 17 gm. of chloramphenicol was given over a period of eight days during the initial illness. A clinical relapse occurred 12 days after treatment was discontinued, but this responded promptly to a second course of drug.
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Early in the work frequent cultures taken at intervals of several hours throughout the first day of treatment consistently gave negative results. There was an inclination to discount these observations since no method was available for inactivating chloramphenicol, and it was thought possible that sufficient drug might be present in the sample to prevent growth. Subsequent observations on four of the patients in this series indicated that such might not be the principal determining factor 4 in the negative results. S. typhosa were grown from specimens taken from two patients 24 hours after therapy was initiated and from specimens obtained from two other patients at 48 hours. Except for these positive results and the cultures obtained during the clinical relapses, bacteremia was not demonstrated after therapy was begun.
Nine of the 24 patients listed in Table I did not have demonstrable S. typhosa in their stools at any time during the course of observation. Ten of the 24 patients had S. typhosa in their stools prior to treatment but two of these (patients 18 and 23) did not excrete these organisms at any time after drug was administered. Among the remaining 13, S. typhosa occurred on one or more occasions after beginning chloramphenicol therapy; five of these had positive cultures after the drug was discontinued and, of these, four developed typical clinical relapses. None of the patients in the present group developed the chronic carrier state during the period of observation. Each individual provided three consecutive stool specimens which were negative for S. typhosa before being discharged from the hospital. In Table I is given the last day of the disease on which S. typhosa was found in the stool of each patient. Figures 1 to 4 illustrate the typical findings. During the first day the levels usually ranged between 40 and 80 gamma /cc. but on occasion values as high as 100 were attained. During the subsequent three to five days the levels generally ranged between 20 and 40 gamma/cc. Those patients treated late in the series with a prolonged course of drug received 1.5 gm. daily in divided doses of 0.5 gm. at intervals of eight hours during the last five to seven days of treatment. While frequent blood levels were not obtained in this group, other observations (6) indicate that oral doses of 0.5 gm. of chloramphenicol provide blood levels of 10 to 20 gamma/cc. during the first few hours after the dose is given and that the level is barely detectable at the end of eight hours.
In this group of treated patients, as in others previously studied (1, (7) (8) (9) , there were no evidences of toxic manifestations attributable to the chloramphenicol. Abnormalities in the white and red blood cells and in the urine were recorded in a number of instances but were considered to be part of the disease picture of typhoid or of the complications which developed.
The effect of chloramphenicol on the typhoid carrier state Results of therapy. Four adult women, who were known to have been carriers of S. typhosa for ten or more years, were studied bacteriologically until two or more specimens of duodenal contents or stool were shown to contain typhoid bacilli. Following proof of the carrier state, each patient received an initial oral dose of 60 mgm.
per kgm. of body weight of chloramphenicol; this was followed by a total of 4.0 to 6.0 gm. daily given in divided doses every six hours. Each patient received an average of 71 gm. of the antibiotic over a 15-day period. High blood concentrations were obtained without exception; the over-all average was 38 gamma/cc. An attempt was made to follow the antibiotic level in bile ob-tained by duodenal aspiration two hours after each dose was given, but results were erratic and unreliable, presumably because of unabsorbed drug present in the duodenal fluids.
Duodenal drainage fluid from each patient became negative for S. typhosa within two to six days after therapy was initiated, and remained so for the duration of treatment. However, in the majority of instances, the concentrations of chloramphenicol in these samples were sufficiently high to be expected to inhibit growth of the organisms in the (patient D) during the period of treatment allowed a careful bacteriologic study to be done. Cultures of bile, obtained from the common duct and from the gallbladder, and also from scrapings of the wall of the bladder itself, gave negative results for S. typhosa. However, a crushed stone yielded a positive culture for typhoid bacilli. It is of interest that S. typhosa subsequently reappeared in the duodenal contents of this patient in spite of cholecystectomy and chloramphenicol therapy. These observations indicate that chloramphenicol therapy in four chronic typhoid carriers was consistently unsatisfactory in eradicating the carrier state.
Chloramphenicol levels in bile of human beings. Two patients suitable for the study of biliary excretion of chloramphenicol were observed during the period covered by this report. The first of these, an adult female, had a carcinoma of the stomach without evidence of biliary obstruction. She was given a single oral 4.0 gm. dose of chloramphenicol three hours prior to an exploratory laparotomy. At the time of the operation simultaneous specimens of blood and bile were obtained, the latter by direct aspiration of the gallbladder. Bioassay5 of these samples revealed antibiotic levels of 69 and 27 gamma/cc. in blood and bile, respectively.
The second was the chronic typhoid carrier (patient D) whose gallbladder had been removed recently. She was studied during convalescence from the operation at the time that a "T tube" drain was present in the common duct. On two occasions single oral doses of 2.0 and 4.0 gm. of chloramphenicol were given to this patient. Bioassay of samples of blood and bile taken simultaneously at intervals after the oral dose demonstrated that antibiotic levels in the bile were approximately 50 per cent of those in the blood, although the maximum levels reached were dependent, of course, on dosage. The results obtained in this patient with the 4.0 gm. test dose are shown in Figure 5 . 5 The bioassay technique of Joslyn and Galbraith (2, 3) must be modified to allow satisfactory estimation of chloramphenicol levels in bile. The specimen is centrifuged to remove all particulate matter and the clear supernatant fluid is used in the assay as though it were serum. To reduce non-specific light absorption due to the color of the bile, the optical densities of the tubes of the assay are read at a wave-length of 800 millimicrons.
RESULTS IN PATIENTS GIVEN AUREOMYCIN AND POLYMYXIN
Aureomycin Four American patients with typhoid fever were given aureomycin orally beginning on the 12th to 16th day after onset of illness. Two of the patients died. One, a seven-year-old boy, succumbed to the toxemia of the disease on the 22nd day of illness after receiving a total of 13.8 gm. of drug over seven days. His sister, patient 12 in Table I , recovered promptly on chloramphenicol therapy. The other fatal case was a 42-year-old man who died on the 19th day of disease after taking 13.0 gm. of antibiotic during the three days prior to death. In the two remaining patients some reduction in fever occurred for a few days after instituting therapy but this was not accompanied by an obvious decrease in the toxemic manifestations of typhoid fever. Figure 6 illustrates graphically the course of disease in one of these patients who received a total of 59.1 gm. of aureomycin between the 12th and 26th days of illness and became afebrile after the period covered by the chart. The other patient who survived was given 22.2 gm. of drug between the 15th and 28th days and remained afebrile after the 27th day of disease.
Although our experience with aureomycin in typhoid fever has been limited, it has been uniformly discouraging. This is in contrast to the equivocal preliminary results reported by Collins and his coworkers (4).
Polymyxin
Five Chinese patients in Malaya who were severely ill with typhoid fever were treated with polymyxin. The mean day of illness on which therapy was begun was 17, range 10 to 27; the total course of drug administered per patient averaged 3.1 gm. given over 13.8 days; the duration of fever after treatment was instituted averaged 22 days, range 17 to 27; and the last febrile day of primary illness, exclusive of relapses, averaged 38.6 days. There were no fatalities. One patient suffered a moderately severe intestinal hemorrhage and another had severe furunculosis which responded to treatment with penicillin. Three Twenty-four patients with typhoid fever were treated with chloramphenicol. There were no fatalities. In one group, consisting of 22 patients, therapy was begun within the first three weeks of illness, average 11.9 days, while the two members of the other group first received the drug during a relapse which occurred in the fifth or seventh week. The average duration of fever after the initial dose of drug was 3.5 days in the first group and 2.5 days in the second. The majority of the patients in the first group recovered without complications, but two had intestinal hemorrhage, one had intestinal perforation, and four had clinical relapses. The group of 22 patients received on the average a total of 23.4 gm. of drug given over 9.2 days. It should be noted that the relapses developed in individuals who received less than the average course of therapy, and that they were readily controlled when drug was again administered.
It is evident from the study of this first series of patients that chloramphenicol is a valuable therapeutic agent in the treatment of typhoid fever. It must be realized, however, that the patients become afebrile before the intestinal lesions are healed and, as a result, hemorrhage and perforation may occur after defervescence. The present observations indicate that a relatively high incidence of relapses may be expected if chloramphenicol therapy is restricted to a period of less than eight days.
None of the patients who received chloramphenicol therapy became chronic typhoid carriers. In nine of the 22 persons treated during their primary illness, S. typhosa were never recovered from the stools and in none of the 24 persons in this series were typhoid organisms ever found in the urine. Five individuals had S. typhosa in their feces after drug therapy was discontinued. Four of these developed clinical relapses. Eventually the stools of all five became free of S. typhosa, the last positive culture being obtained on the 50th day after onset.
Large doses of chloramphenicol given over a period of two weeks to four typhoid carriers failed to eradicate permanently the carrier state. During the treatment, when the level of chlorampheni-col in the bile was about half that in the blood, no S. typhosa were grown from specimens of biliary fluid. Typhoid organisms were again cultivated from the bile shortly after the drug was discontinued. It is worth mentioning that concentrations of chloramphenicol as high as 1,000 gamma/cc. have no detectable in vitro bactericidal effect on S. typhosa (our unpublished data). Furthermore, in typhoid fever, as in scrub typhus (6, 9), chloramphenicol therapy apparently only suppresses the growth of the organism; ultimate recovery seems dependent on the development of immunity in the host. Therefore, although not anticipated, the discouraging results in typhoid carriers should probably have been expected.
The results in four patients with typhoid fever treated with aureomycin and in five given polymyxin indicated that little value was obtained from these antibiotics. Indeed, the course was essentially unaltered from that of the nine patients with typhoid fever who received only supportive therapy in the present investigation or the large numbers of patients reported in earlier studies by others.
